Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.200
-0.080 (-3.51%)
At close: Jan 23, 2026, 4:00 PM EST
2.300
+0.100 (4.55%)
After-hours: Jan 23, 2026, 5:59 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $8.36 million as of January 23, 2026. Its market cap has increased by 21.22% in one year.
Market Cap
8.36M
Enterprise Value
4.41M
1-Year Change
21.22%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $8.36M, a decrease of -99.27%. That is a compound annual growth rate of -65.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 8.67M | 25.27% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 9.34M |
| PharmaCyte Biotech | 9.11M |
| MetaVia | 8.95M |
| Aptevo Therapeutics | 8.91M |
| Evogene | 8.87M |
| XTL Biopharmaceuticals | 8.75M |
| TransCode Therapeutics | 8.55M |
| Immuron | 8.45M |